Dow pairs cost-out execution with a cautious cyclical outlook

Transcript intelligence

What changed

Dow shifted its emphasis toward the Transform to Outperform program and broader cash-support actions, while delaying the Alberta Path to Zero project by two years. Capacity rationalization continued, Q1 2026 EBITDA guidance was maintained at $750 million, and management cited margin expansion despite higher planned turnaround spending.

Guidance delta

Maintained: Q1 2026 EBITDA guidance is $750 million, compared with reported Q4 2025 EBITDA of $741 million.

Key takeaways

• Dow reported Q4 2025 EBITDA of $741 million amid seasonal demand weakness and margin compression.
• Management said more than $6 billion of near-term cash-support actions had been identified and that the cost-out program remained on track.
• Transform to Outperform targets $2 billion of near-term EBITDA improvement through productivity gains and growth.
• The Alberta Path to Zero project was delayed by two years, while management retained an 8%–10% return target.
• Q1 2026 EBITDA guidance calls for $750 million, with expected margin expansion partly offset by higher turnaround spending.

Management priorities

• Execute the remaining cost-out savings for 2025 and the additional savings targeted for 2026.
• Roll out Transform to Outperform, including productivity gains, growth initiatives, automation and workforce reduction.
• Rationalize high-cost upstream assets in Europe and North America.
• Advance the Poly 7 polyethylene train, alkoxylation capacity and silicone-related growth opportunities.
• Reassess and execute the delayed Path to Zero project toward its revised late-2029 completion target.